Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane

M Kawahara1, N Arispe, Y Kuroda

  • 1Department of Molecular and Cellular Neurobiology, Tokyo Metropolitan Institute for Neuroscience, Japan.

Biophysical Journal
|July 1, 1997
PubMed

Insights

Amyloid beta-protein (AβP[1-40]) forms cation-selective channels in natural GnRH neuron membranes, similar to artificial ones. Zinc ions block these channels, suggesting a role in AβP[1-40] neurotoxicity.

Area of Science:

  • Neuroscience
  • Biophysics
  • Molecular Biology

Background:

  • Amyloid beta-protein (AβP[1-40]) forms cation-selective channels in artificial membranes.
  • Investigating AβP[1-40] channel formation in natural neuronal membranes is crucial for understanding its neurotoxicity.

Purpose of the Study:

  • To determine if AβP[1-40] forms cation-selective channels in natural neuronal membranes.
  • To characterize the properties of these channels and the effect of zinc ions.
  • To investigate the in vivo association of AβP[1-40] with neuronal membranes.

Main Methods:

  • Utilized excised membrane patches from GnRH neurons.
  • Performed electrophysiological recordings to measure channel activity and ion flow.
  • Employed immunocytochemical confocal microscopy to visualize AβP[1-40] deposits.

Main Results:

  • AβP[1-40] spontaneously formed cation-selective channels in GnRH neuron membrane patches.
  • Channel conductance varied (50-500 pS) and followed ion gradients.
  • Zinc ions blocked channel activity, reversible by o-phenanthroline, indicating direct interaction.
  • AβP[1-40] deposits were observed associated with GnRH neuron plasma membranes in vivo.

Conclusions:

  • AβP[1-40] forms functional cation-selective channels in natural neuronal membranes.
  • Zinc binding to AβP[1-40] channels influences their function.
  • These findings support the hypothesis that AβP[1-40] channel formation contributes to neurotoxicity.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...